The Pro-Seq technology links molecules prior to sequencing to enable detection of low-frequency variants, and could be complementary to Boreal's OnTarget technology.
The USC spinout is also developing nanoparticles for targeted sequencing, biomolecule isolation, and other applications.
The company aims to commercialize a sequencing instrument based on Helicos' technology and has secured orders from a Shanghai-based genomics startup.
The Bay Area startup has designed a menu of apps related to sleep, caffeine metabolism, and other indications.
Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.
The firms plan to focus on sample processing methods, workflow automation, algorithms, and database construction.
At a conference last week, researchers from Italy presented results from 73 women who had mosaic embryos transferred.
In a revised medical policy, Aetna said it would continue to cover NIPT for high-risk pregnancies, but not average-risk ones.
The company, a division of BGI Group, sold 40.1 million shares at RMB 13.64 per share for a total of RMB 547 million ($80.6 million) in the offering.
Recently launched tests that screen for single-gene disorders are prompting questions about what is appropriate to screen for prenatally.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.